Filing Details
- Accession Number:
- 0001181431-12-019176
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-23 10:02:39
- Reporting Period:
- 2012-03-22
- Filing Date:
- 2012-03-23
- Accepted Time:
- 2012-03-23 10:02:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1338042 | Aegerion Pharmaceuticals Inc. | AEGR | Pharmaceutical Preparations (2834) | 202960116 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1314575 | D Marc Beer | C/O Aegerion Pharmaceuticals, Inc. 101 Main Street, Ste 1850 Cambridge MA 02142 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-03-22 | 1,000 | $13.96 | 198,061 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 197,061 | Direct | |
Common Stock | 7,156 | Indirect | by Roth IRA |
Common Stock | 200 | Indirect | By son |